AI chatbot aims to lift mood in stroke survivors
NCT ID NCT07336888
First seen Jan 14, 2026 · Last updated Jun 21, 2026 · Updated 28 times
Summary
This study tests whether a chatbot on the Doubao app can reduce depression in people who have had a stroke. Researchers will enroll 240 participants and use the chatbot to provide positive psychological counseling. The main goal is to see if depression scores improve, with quality of life also measured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
positive psychological counseling chatbot on Doubao software
What this could lead to
If it works, this could offer a low-cost, accessible way to help stroke survivors manage depression symptoms at home.
What could go wrong
This is an early-stage study with no control group comparison yet. The chatbot may not be effective for everyone, and results depend on user engagement.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.